Johnson & Johnson's recalls infant, children's   Tylenol, Motrin

WASHINGTON

Sun May 2, 2010 1:37am EDT

WASHINGTON (Reuters) - The Food and Drug Administration on Saturday urged consumers to stop using liquid Tylenol, Motrin, Benadryl and Zyrtec medicines for children and infants after a broad recall announced by the manufacturer, although it said the chance of serious problems was remote.

U.S.  |  Health

Johnson & Johnson's consumer division announced a broad recall of products, including certain liquid infant's and children's Tylenol, Motrin, Zyrtec, and Benadryl products late on Friday.

A full list of the over 40 affected products made by McNeil Consumer Healthcare is available at www.mcneilproductrecall.com

"We want to be certain that consumers discontinue using these products," FDA Commissioner Margaret Hamburg said in a statement.

"While the potential for serious health problems is remote, Americans deserve medications that are safe, effective and of the highest quality. We are investigating the products and facilities associated with this recall and will provide updates as we learn more," she said.

McNeil said it was recalling the products in consultation with the FDA after discovering manufacturing deficiencies that could affect the quality, purity or potency of the medicines.

The FDA said some of the products may not meet required quality standards, and parents and caregivers should stop administering them to children and switch to generic brands, which are not affected by the recall.

They said consumers should not administer adult strength medicine to infants or children since that could result in serious harm.

Some of the products affected by the recall may contain a higher concentration of active ingredient than specified; others contain inactive ingredients that may not meet internal testing requirements; and others may contain tiny particles, the FDA said.

The FDA said the chance of an adverse reaction was remote, but urged consumers to contact their doctors and the FDA if their children exhibited any symptoms.

McNeil Consumer said it was recalling all lots of the over-the-counter products. The medicines were manufactured in the United States and distributed in the United States, Canada, the Dominican Republic, Dubai, Fiji, Guam, Guatemala, Jamaica, Puerto Rico, Panama, Trinidad and Tobago, and Kuwait.

It said consumers with questions about the recall could contact the company at 1-800-222-6036 or the website.

(Reporting by Andrea Shalal-Esa; Editing by Eric Beech)

       （大概给大家翻译下）路透社昨日消息：美国FDA建议孩子家长停止给儿童或者婴幼儿服用强生公司生产的泰诺林和美林口服液等系列产品，厂家已宣布开始召回。

        FDA发言人称：尽管这些药物可能造成的损害近期还不可知，但召回的部分产品中存在成分、纯度等质量问题，没有达到相关的质量标准。在进行进一步调查前，FDA强烈建议家长们停止给宝宝们服用上述产品，以免给宝宝身体造成伤害。

       尽管公告中提及的药品召回国家没有中国，但据我所知，泰诺林、美林口服液在国内正广泛使用，在很多医院儿科是常规药物。记得几个月前俺家宝宝发烧，我给他服用的就是小美林口服液！！

      令人吃惊的是，这样几种在医院、门诊广泛使用的药物竟然存在问题，试想，若不仅仅是药品生产问题，而是药物本身可能侵害孩子们的健康，那这类药物就有可能有全世界范围退市的可能。

      于我，如同当年的祥林嫂，原以为只有冬天才会有狼，没想到春天也会有！